Joel Greenblatt fit · Magic Formula — ROIC alto + EV/EBIT barato
Is CytomX Therapeutics, Inc. (CTMX) a Joel Greenblatt Stock?
Partial match — either cheap or high-quality, but not both.
44/100
DSinais mistos
4/5 critérios atendidos
Os critérios de Joel Greenblatt, aplicados a CTMX
EBIT/EV yield ≥ 10%
chave45.9%
ROIC ≥ 25%
chave62.2%
EV/EBIT ≤ 12
2.2x
Gross margin ≥ 30%
100.0%
Como CTMX pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$969.17M
P/L (TTM)
14.2x
ROIC (TTM)
62.2%
Margem bruta
100.0%
Perguntas frequentes
What is CTMX's Joel Greenblatt fit score?
CTMX scores 44/100 on our Joel Greenblatt fit engine — grade D. Partial match — either cheap or high-quality, but not both.
Does Joel Greenblatt actually own CTMX?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends CTMX.
How often is this score updated?
CTMX's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Joel Greenblatt possua ou recomende CTMX pessoalmente.